News

SCAI, 2015, Scientific Sessions, highlights, angiography

The Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will take place May 6-9 in San Diego, California. SCAI 2015 will deliver updates affecting the invasive...

Edwards Lifesciences Corp. announced that chairman and CEO Michael A. Mussallem served as an invited expert panelist on behalf of the Advanced Medical Technology Association (AdvaMed) at the...

TAVR, transcatheter heart valves, GlobalData, TMVR

Research and consulting firm GlobalData reported that the global market value for transcatheter heart valves will expand at a Compound Annual Growth Rate (CAGR) of 19.7 percent through 2020,...

Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack...

Cardiac visualization and analysis software provider Epsilon Imaging announced the results of four studies presented at the ACC 2015 that demonstrated improved quality in assessment of heart...

March 26, 2015 — Siemens Healthcare introduced a new angiography system and new cardiac ultrasound apps at the 2015 American College of Cardiology (ACC) annual meeting.  

congenital heart disease, CHD, tPVR, consensus paper, minimally invasive

A new expert consensus paper released by a coalition of cardiovascular organizations provides guidance on transcatheter pulmonic valve replacement (tPVR) for children and adults who were...

Bendavia, heart attack, scarring, angioplasty, ACC, study

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a...

Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015

he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed...

Patients who experience the deadliest form of heart attack — ST-segment elevation myocardial infarction (STEMI) — and suffer from substantial narrowing in multiple heart arteries may benefit from...

BEST Trial

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were...

A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing...

Toshiba, CT angiography, Infinix 4D CT

The U.S. Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems new Infinix 4D CT system to enable computed tomography (CT) imaging directly in the cath lab. It integrates...

Bonn Call for Action, FDA, radiation exposure, medical imaging, update

The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the...

Impella, FDA, high risk PCI, abiomed

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary...

JAMA, intracranial arterial stenosis, balloon expandable stents, medication

A study in the March 24/31 issue of JAMA found that using balloon-expandable stents to treat symptomatic intracranial arterial stenosis resulted in an increased risk of stroke or...

Patients over age 80 with acute coronary syndromes would likely benefit from more invasive tests and therapies that may otherwise be denied them due to their age, according to research presented...

atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two coprimary endpoints — a composite...

Mitralign, transcatheter triscupid repair, TTVR, TR, first in human

A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department...

Mitraclip, abbott, mitral valve repair, ACC, transcatheter mitral valve repair

The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S....